Abstract
Ischemic stroke is a disease with a very high incidence in the clinic, and hypertension is the most important variable risk factor of ischemic stroke. Studies have shown that intestinal microbes are involved in the occurrence and development of various diseases. This study aims to explore whether intestinal microbes play an important role in the pathogenesis of ischemic stroke in a hypertensive population. In this study, the inpatients in the Department of Neurology and Cardiology of the Second Affiliated Hospital of Shandong First Medical University in April 2021 were selected, including seven patients with hypertension complicated with ischemic stroke and only seven patients with hypertension. After collecting the stool samples of patients, the gene sequence of the samples was detected by 16S rRNA sequencing technology, and the double-ended 2 × 150 bp sequencing was carried out. After sequencing, the results were analyzed by diversity analysis, species difference analysis, species function difference analysis, and other bioinformatics tests. According to the test results, serum proteomics and biochemical blood tests were carried out to verify. There was no significant difference in α diversity and β diversity between hypertension complicated with the cerebral infarction and hypertension groups. LEfSe analysis showed that at the genus level, compared with the hypertension group, Bacteroides, UCG_009, and Eisenbergiella had significantly increased relative abundance. The genera with relatively significantly reduced abundance are Ruminococcus_gnavus_group, Sutterellaceae, Burkholderia, and Prevotella and the LDA score of Prevotella is < − 4, which indicates that there are significant differences. Compared with the blood biochemical indexes, the results showed that the level of APOA1 in hypertensive patients with ischemic stroke was significantly higher than that in hypertensive patients (p < 0.05), but there was no significant difference in total cholesterol (CHOL), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein B (APOB), and free fatty acid (NEFA). Proteomic analysis showed that there were 89 up-regulated genes and 51 down-regulated genes in the serum of the two groups, and the expression of APOC2 and APOC3 in the cerebral infarction group with hypertension was significantly higher than that in the hypertension group (p < 0.05). The intestinal diversity of patients with hypertension complicated with stroke is similar to that of patients with hypertension, but there are differences in microbiota, among which Prevotella is the most significant. Prevotella could affect lipid metabolism so that APOC2 and APOC3 in the blood are significantly increased, leading to cerebral artery atherosclerosis and, finally, ischemic stroke. This provides a new idea for preventing and treating ischemic stroke in patients with hypertension, but the mechanism of Prevotella acting on apolipoprotein needs further verification by basic medical research.
Similar content being viewed by others
Data Availability
The data sets generated and analyzed during the study are available from the corresponding author on reasonable request.
References
Accetto T, Avguštin G (2021) Non-oral Prevotella stepping into the spotlight. Anaerobe 68:102321. https://doi.org/10.1016/j.anaerobe.2021.102321
Barko PC, McMichael MA, Swanson KS, Williams DA (2018) The gastrointestinal microbiome: a review. J Vet Intern Med 32(1):9–25. https://doi.org/10.1111/jvim.14875
Bellmaine S, Schnellbaecher A, Zimmer A (2020) Reactivity and degradation products of tryptophan in solution and proteins. Free Radical Biol Med 160:696–718. https://doi.org/10.1016/j.freeradbiomed.2020.09.002
Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG, Iadecola C, Anrather J (2016) Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat Med 22(5):516–523. https://doi.org/10.1038/nm.4068
Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA et al (2019) Reproducible interactive scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37(8):852–857. https://doi.org/10.1038/s41587-019-0209-9
Chen H, Jiang W (2014) Application of high-throughput sequencing in understanding human oral microbiome related with health and disease. Front Microbiol 5:508. https://doi.org/10.3389/fmicb.2014.00508
Chen W, Zhang S, Wu J, Ye T, Wang S, Wang P, Xing D (2020a) Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clinica chimica acta; Int J Clin Chem 507:236–241. https://doi.org/10.1016/j.cca.2020.04.037
Chen XF, Chen X, Tang X (2020b) Short-chain fatty acid, acylation and cardiovascular diseases. Clin Sci (London, England : 1979), 134(6):657–676. https://doi.org/10.1042/CS20200128
Chen J, Qin Q, Yan S, Yang Y, Yan H, Li T, Wang L, Gao X, Li A Ding S (2021) Gut microbiome alterations in patients with carotid atherosclerosis. Front Cardio Med 8:739093. https://doi.org/10.3389/fcvm.2021.739093
Christensen L, Vuholm S, Roager HM, Nielsen DS, Krych L, Kristensen M, Astrup A, Hjorth MF (2019) Prevotella abundance predicts weight loss success in healthy, overweight adults consuming a whole-grain diet ad libitum: a post hoc analysis of a 6-Wk randomized controlled trial. J Nutr 149(12):2174–2181. https://doi.org/10.1093/jn/nxz198
Cipolla MJ, Liebeskind DS, Chan SL (2018) The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 38(12):2129–2149. https://doi.org/10.1177/0271678X18800589
Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461–478. https://doi.org/10.1038/s41575-019-0157-3
Diener HC, Hankey GJ (2020) Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol 75(15):1804–1818. https://doi.org/10.1016/j.jacc.2019.12.072
Edgar RC (2016) UNOISE2: improved error-correction for Illumina 16S and ITS ampliconsequencing. https://doi.org/10.1101/081257
Eriksen AK, Brunius C, Mazidi M, Hellström PM, Risérus U, Iversen KN, Fristedt R, Sun L, Huang Y, Nørskov NP, Knudsen KEB, Kyrø C, Olsen A, Tjønneland A, Dicksved J, Landberg R (2020) Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial. Am J Clin Nutr 111(4):864–876. https://doi.org/10.1093/ajcn/nqaa026
Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355–1359. https://doi.org/10.1126/science.1124234
Gomaa EZ (2020) Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 113(12):2019–2040. https://doi.org/10.1007/s10482-020-01474-7
Grieb P (2014) Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs 28(3):185–193. https://doi.org/10.1007/s40263-014-0144-8
Guevara-Cruz M, Flores-López AG, Aguilar-López M, Sánchez-Tapia M, Medina-Vera I, Díaz D, Tovar AR, Torres N (2019) Improvement of lipoprotein profile and metabolic endotoxemia by a lifestyle intervention that modifies the gut microbiota in subjects with metabolic syndrome. J Am Heart Assoc 8(17):e012401. https://doi.org/10.1161/JAHA.119.012401
Hu W, Kong X, Wang H, Li Y, Luo Y (2022) Ischemic stroke and intestinal microbiota: an insight into brain-gut axis. Eur J Med Res 27(1):73. https://doi.org/10.1186/s40001-022-00691-2
Hu FZ, Król JE, Tsai CHS, Eutsey RA, Hiller LN, Sen B, Ahmed A, Hillman T, Buchinsky FJ, Nistico L, Dice B, Longwell M, Horsey E, Ehrlich GD (2019) Deletion of genes involved in the ketogluconate metabolism, Entner-Doudoroff pathway, and glucose dehydrogenase increase local and invasive virulence phenotypes in Streptococcus pneumoniae. PloS one 14(1):e0209688. https://doi.org/10.1371/journal.pone.0209688
Konukoglu D, Uzun H, Islam MS (2017) Hypertension: from basic research to clinical practice. Endothelial dysfunction and hypertension. Springer International Publishing Cham, pp 511–540
Li N, Wang X, Sun C, Wu X, Lu M, Si Y, Ye X, Wang T, Yu X, Zhao X, Wei N, Wang X (2019) Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiol 19(1):191. https://doi.org/10.1186/s12866-019-1552-1
Liang H, Jiang F, Cheng R, Luo Y, Wang J, Luo Z, Li M, Shen X, He F (2021) A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice. Exp Anim 70(1):73–83. https://doi.org/10.1538/expanim.20-0094
Matthews DE (2020) Review of lysine metabolism with a focus on humans. J Nutr 150(Suppl 1):2548S–2555S. https://doi.org/10.1093/jn/nxaa224
Medina-Vera I, Sanchez-Tapia M, Noriega-López L, Granados-Portillo O, Guevara-Cruz M, Flores-López A, Avila-Nava A, Fernández ML, Tovar AR, Torres N (2019) A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes. Diabetes Metab 45(2):122–131. https://doi.org/10.1016/j.diabet.2018.09.004
Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3):189–200. https://doi.org/10.1080/19490976.2015.1134082
Ohira H, Tsutsui W, Fujioka Y (2017) Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb 24(7):660–672. https://doi.org/10.5551/jat.RV17006
Paul S, Candelario-Jalil E (2021) Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol 335:113518. https://doi.org/10.1016/j.expneurol.2020.113518
Price RS, Kasner SE (2014) Hypertension and hypertensive encephalopathy. Handb Clin Neurol 119:161–167. https://doi.org/10.1016/B978-0-7020-4086-3.00012-6
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO (2012) The SILVA ribosomal RNA gene database project: improved data processing and web-based tool. Nucleic Acids Res 41(D1):D590–D596. https://doi.org/10.1093/nar/gks1219
Rognes T, Flouri T, Nichols B, Quince C, Mahé F (2016) VSEARCH: a versatile open source tool for metagenomics. PeerJ 4:e2584. https://doi.org/10.7717/peerj.2584
Roy-O’Reilly M, McCullough LD (2018) Age and sex are critical factors in ischemic stroke pathology. Endocrinology 159(8):3120–3131. https://doi.org/10.1210/en.2018-00465
Santisteban MM, Ahn SJ, Lane D, Faraco G, Garcia-Bonilla L, Racchumi G, Poon C, Schaeffer S, Segarra SG, Körbelin J, Anrather J, Iadecola C (2020) Endothelium-macrophage crosstalk mediates blood-brain barrier dysfunction in hypertension. Hypertension (Dallas, Tex. : 1979) 76(3):795–807. https://doi.org/10.1161/HYPERTENSIONAHA.120.15581
Sarikaya H, Ferro J, Arnold M (2015) Stroke prevention–medical and lifestyle measures. Eur Neurol 73(3–4):150–157. https://doi.org/10.1159/000367652
Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164(3):337–340. https://doi.org/10.1016/j.cell.2016.01.013
Sindler AL, Devan AE, Fleenor BS, Seals DR (2014) Inorganic nitrite supplementation for healthy arterial aging. J Appl Physiol (Bethesda, Md. : 1985) 116(5):463–477. https://doi.org/10.1152/japplphysiol.01100.2013
Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, Dichgans M, Liesz A (2016) Microbiota dysbiosis controls the neuroinflammatory response after stroke. The Journal of Neuroscience : the Official Journal of the Society for Neuroscience 36(28):7428–7440. https://doi.org/10.1523/JNEUROSCI.1114-16.2016
Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15(1):73. https://doi.org/10.1186/s12967-017-1175-y
Synoradzki K, Grieb P (2019) Citicoline: a superior form of choline? Nutrients 11(7):1569. https://doi.org/10.3390/nu11071569
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368(17):1575–1584. https://doi.org/10.1056/NEJMoa1109400
Tett A, Pasolli E, Masetti G, Ercolini D, Segata N (2021) Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol 19(9):585–599. https://doi.org/10.1038/s41579-021-00559-y
Xia X, Li G, Ding Y, Ren T, Zheng J, Kan J (2017) Effect of Whole Grain Qingke (Tibetan Hordeum vulgare L. Zangqing 320) on the serum lipid levels and intestinal microbiota of rats under high-fat diet. J Agric Food Chem 65(13):2686–2693. https://doi.org/10.1021/acs.jafc.6b05641
Yin J, Liao SX, He Y, Wang S, Xia G-H, Liu F-T, Zhu J-J, You C, Chen Q, Zhou L, Pan S-Y, Zhou H-W (2015) Dysbiosis of gut microbiota with reduced trimethylamine‐N‐oxide level in patients with large‐artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 4(11). https://doi.org/10.1161/JAHA.115.002699
You C, Zeng X, Gao X, Tan C, He Y, Zhou H et al (2018) Study on the disturbance and recovery of intestinal flora in patients with cerebral infarction[J]. Chin J Neuropsychiatric Dis 44(03):149–154
Zeng X, Gao X, Peng Y, Wu Q, Zhu J, Tan C, Xia G, You C, Xu R, Pan S, Zhou H, He Y, Yin J (2019) Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut. Front Cell Infect Microbiol 9:4. https://doi.org/10.3389/fcimb.2019.00004
Zhang WT, Niu JY, He C (2020) Associations of OSAHS complicated by cerebral infarction with intestinal microbiota, inflammatory factors, homocysteine and adiponectin expression. Eur Rev Med Pharmacol Sci 24(24):12993–12999. https://doi.org/10.26355/eurrev_202012_24204
Funding
We are grateful for the support from the Tai’an Science and Technology Innovation Development Project (2020NS267 and 2021NS300) and Shandong Medicine and Health Science and Technology Plan Development Project (202103090628).
Author information
Authors and Affiliations
Contributions
Zhang Xiaowei, as a correspondent, put forward the topic and specified the research scheme. Jiang Yitong and Liu Chunhua, as the first authors, sorted out the experimental data and wrote a paper. Zhang Yingli and Ying Mei are responsible for data collection. Xiao Feng and Chen Miao are responsible for revising the paper. Zhang Yong is responsible for the analysis of clinical data.
Corresponding author
Ethics declarations
Ethical Approval
This study was approved by the Ethics Committee of the Shandong First Medical University (2023-011), China. And all experiments were conducted in accordance with the regulations on the management of laboratory animals promulgated by the Ministry of Science and Technology of the People’s Republic of China (1988, No. 134).
Informed Consent
A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject’s decision to participate.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, Y., Liu, C., Zhang, Y. et al. Analysis of Fecal Microbiota in Patients with Hypertension Complicated with Ischemic Stroke. J Mol Neurosci 73, 787–803 (2023). https://doi.org/10.1007/s12031-023-02149-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-023-02149-4